Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biden Turns To Cold War Measure To Expand Access to COVID-19 Tests

Executive Summary

President Biden outlined his pandemic strategy in a speech from the White House Thursday. The president invoked the Defense Production Act to quicken the availability of tests and issued a series of steps to increase vaccinations, including mandates.

You may also be interested in...



The Time Is Now: Paper Argues US Needs National Diagnostics Plan Before The Next Pandemic

The US needs a comprehensive plan to meet the country's testing needs in the earliest stages of an infectious disease crisis, according to a paper posted by the John Hopkins Center for Health Security. The authors of the paper say government and industry collaboration is essential in creating such a plan and urge both sectors to act now. 

Top Republican Senators Criticize Biden Administration For Lack Of COVID-19 Tests

The top GOPers on the Senate health committee want to know what the administration has done with more than $80bn allocated by Congress to ramp up production of COVID-19 tests.

Biden Promises 500 Million COVID-19 Tests As Omicron Threatens To Overwhelm US Health Care System

The “President’s Winter Plan” to fight the new variant includes mailing out free COVID-19 take-home tests to Americans who ask for it. AdvaMed says it will encourage manufacturers to keep producing tests.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT144447

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel